Human Formulations Portfolio

Finished Pharmaceutical
Formulations

Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.

8+Product Categories

500+Product Variants

MultipleDosage Forms

GMPQuality Sourced

Clear Filters
RFQ List (0)
Human Formulations

532 products available

Page 8 of 22

Dry Syrup / Oral LiquidsSingle

Colistin Sultate 12.5mg /5ml Oral Suspension

Oral Suspension / Dry Syrup

Colistin Sultate 12.5mg /5ml Oral Suspension is a oral suspension / dry syrup formulated with Colistin Sultate 12.5mg /5ml. The listed active ingredient profile is Colistin Sultate, placing the product in the antibacterial category. The active ingredient

Available strengths
Colistin Sultate 12.5mg /5ml
Diabetic RangeSingle

Dapagliflozin 10 mg + Metformin IP S00 mg (Film coated Tablet)

Tablet

Dapagliflozin 10 mg + Metformin IP S00 mg (Film coated Tablet) is a tablet formulated with Dapagliflozin 10 mg + Metformin IP S00 mg ( ). The listed active ingredient profile is Dapagliflozin; Metformin S00 mg, placing the product in the oral antidiabetic

Available strengths
Dapagliflozin 10 mg + Metformin IP S00 mg ( )
Diabetic RangeSingle

Dapagliflozin 5mg + Metformin Hydrochloride IP 500 mg (Film coated bilayred Tablet)

Tablet

Dapagliflozin 5mg + Metformin Hydrochloride IP 500 mg (Film coated bilayred Tablet) is a tablet formulated with Dapagliflozin 5mg + Metformin Hydrochloride IP 500 mg ( ). The listed active ingredient profile is Dapagliflozin; Metformin Hydrochloride, plac

Available strengths
Dapagliflozin 5mg + Metformin Hydrochloride IP 500 mg ( )Dapagliflozin 5 mg + Metformin Hydrochloride IP 1000 mg ( )
Diabetic RangeSingle

Dapagliflozin 5mg Tablets (Film coated)

Tablet

Dapagliflozin 5mg Tablets (Film coated) is a tablet formulated with Dapagliflozin 5mg ( ). The listed active ingredient profile is Dapagliflozin, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowe

Available strengths
Dapagliflozin 5mg ( )Dapagliflozin 10mg ( )
Diabetic RangeSingle

Dapagliflozin propanediol monohydrate Eq to dapagliflozine 10mg + Metformin hydrochloride (ER) 1000mg

Tablet

Dapagliflozin propanediol monohydrate Eq to dapagliflozine 10mg + Metformin hydrochloride (ER) 1000mg is a tablet formulated with Dapagliflozin propanediol monohydrate Eq to dapagliflozine 10mg + Metformin hydrochloride (ER) 1000mg. The listed active ingr

Available strengths
Dapagliflozin propanediol monohydrate Eq to dapagliflozine 10mg + Metformin hydrochloride (ER) 1000mg
TabletsSingle

Deflazacort 12 mg Film-Coated Tablet

Film-Coated Tablet

Deflazacort 12 mg Film-Coated Tablet is a film-coated tablet formulated with 12 mg. The active ingredient profile is Deflazacort, placing the product in the corticosteroid category. Deflazacort is a systemic corticosteroid with anti-inflammatory and immun

Available strengths
12 mg
TabletsSingle

Deflazacort 6 mg Uncoated Tablet

Uncoated Tablet

Deflazacort 6 mg Uncoated Tablet is a uncoated tablet formulated with 6 mg. The active ingredient profile is Deflazacort, placing the product in the corticosteroid category. Deflazacort is a systemic corticosteroid with anti-inflammatory and immunosuppres

Available strengths
6 mg18 mg24 mg +1
Topical FormulationsSingle

Desonide 0.05% w/w Methylparaben 0.08%w/w + Propylparaben 0.047%w/w

Topical Formulation

Desonide 0.05% w/w Methylparaben 0.08%w/w + Propylparaben 0.047%w/w is a topical formulation formulated with Desonide 0.05% w/w Methylparaben 0.08%w/w + Propylparaben 0.047%w/w. The listed active ingredient profile is Desonide % w/w Methylparaben w/w; Pro

Available strengths
Desonide 0.05% w/w Methylparaben 0.08%w/w + Propylparaben 0.047%w/w
Topical FormulationsSingle

Desonide IP 0.057%w/w Cream + Preservatves : Methylparaben 0.087%w/w + Propylpargben 0.04% w/w Crear

Cream

Desonide IP 0.057%w/w Cream + Preservatves : Methylparaben 0.087%w/w + Propylpargben 0.04% w/w Crear is a cream formulated with Desonide IP 0.057%w/w + Preservatves : Methylparaben 0.087%w/w + Propylpargben 0.04% w/w Crear. The listed active ingredient pr

Available strengths
Desonide IP 0.057%w/w + Preservatves : Methylparaben 0.087%w/w + Propylpargben 0.04% w/w Crear
Topical FormulationsSingle

Diclofenac Dethyiamine 1.167%w/w Eq. to Diclofenac sodlum 1%w/w + linseed Ol 37%w/w + Methyl Salicylate 10%w/w* Menthol 5%w/w + Capsaicin 0.0257%w/w + Benzyl Alcohol 1%w/w"

Topical Formulation

Diclofenac Dethyiamine 1.167%w/w Eq. to Diclofenac sodlum 1%w/w + linseed Ol 37%w/w + Methyl Salicylate 10%w/w* Menthol 5%w/w + Capsaicin 0.0257%w/w + Benzyl Alcohol 1%w/w" is a topical formulation formulated with Diclofenac Dethyiamine 1.167%w/w Eq. to D

Available strengths
Diclofenac Dethyiamine 1.167%w/w Eq. to Diclofenac sodlum 1%w/w + linseed Ol 37%w/w + Methyl Salicylate 10%w/w* Menthol 5%w/w + Capsaicin 0.0257%w/w + Benzyl Alcohol 1%w/w"
Topical FormulationsSingle

Diclofenac Diethylamine 1.16%w/w Eq. to Diclofenac sodium 1%Awİw + Linseed Oil 3%w/w + Methyl Salicylate 10%w/w + Menthol 59iw/w + thiocolchicoside 0.125%w/w + Benzyl Alcohol 1%w/W'

Topical Formulation

Diclofenac Diethylamine 1.16%w/w Eq. to Diclofenac sodium 1%Awİw + Linseed Oil 3%w/w + Methyl Salicylate 10%w/w + Menthol 59iw/w + thiocolchicoside 0.125%w/w + Benzyl Alcohol 1%w/W' is a topical formulation formulated with Diclofenac Diethylamine 1.16%w/w

Available strengths
Diclofenac Diethylamine 1.16%w/w Eq. to Diclofenac sodium 1%Awİw + Linseed Oil 3%w/w + Methyl Salicylate 10%w/w + Menthol 59iw/w + thiocolchicoside 0.125%w/w + Benzyl Alcohol 1%w/W'
Topical FormulationsSingle

Diclofenac Diethylamine 1.16%w/w Eq. to Diclofenac sodium rw/welinseed Oil 37%w/w + Methyl Salicylate 107%w/w + Menthol 5%w/w + Benzyl Alcohol 1%w/w

Topical Formulation

Diclofenac Diethylamine 1.16%w/w Eq. to Diclofenac sodium rw/welinseed Oil 37%w/w + Methyl Salicylate 107%w/w + Menthol 5%w/w + Benzyl Alcohol 1%w/w is a topical formulation formulated with Diclofenac Diethylamine 1.16%w/w Eq. to Diclofenac sodium rw/weli

Available strengths
Diclofenac Diethylamine 1.16%w/w Eq. to Diclofenac sodium rw/welinseed Oil 37%w/w + Methyl Salicylate 107%w/w + Menthol 5%w/w + Benzyl Alcohol 1%w/w
TabletsSingle

Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium Trisilicate 100 mg Uncoated Tablet

Uncoated Tablet

Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium Trisilicate 100 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium

Available strengths
Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium Trisilicate 100 mg
TabletsSingle

Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg Uncoated Tablet

Uncoated Tablet

Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg. The active ingredient profile is Diclofenac Potassium; Para

Available strengths
Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mgDiclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 500 mg
TabletsSingle

Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chymotrypsin 50,000 IU Tablet

Tablet

Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chymotrypsin 50,000 IU Tablet is a tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chymotrypsin 50,000 IU. The active ingredient profile is Diclofenac Potassium; Paracetamol; Chymo

Available strengths
Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chymotrypsin 50,000 IU
TabletsSingle

Diclofenac Potassium 50 mg + Paracetamol 325 mg + Serratiopeptidase 10 mg Film-Coated Tablet

Film-Coated Tablet

Diclofenac Potassium 50 mg + Paracetamol 325 mg + Serratiopeptidase 10 mg Film-Coated Tablet is a film-coated tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Serratiopeptidase 10 mg. The active ingredient profile is Diclofenac Pot

Available strengths
Diclofenac Potassium 50 mg + Paracetamol 325 mg + Serratiopeptidase 10 mgDiclofenac Potassium 50 mg + Paracetamol 325 mg + Serratiopeptidase 15 mg
TabletsSingle

Diclofenac Potassium 50 mg + Paracetamol 325 mg Uncoated Tablet

Uncoated Tablet

Diclofenac Potassium 50 mg + Paracetamol 325 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg. The active ingredient profile is Diclofenac Potassium; Paracetamol, placing the product in the nsaid + an

Available strengths
Diclofenac Potassium 50 mg + Paracetamol 325 mg
TabletsSingle

Diclofenac Potassium 50 mg + Serratiopeptidase 10 mg Film-Coated Tablet

Film-Coated Tablet

Diclofenac Potassium 50 mg + Serratiopeptidase 10 mg Film-Coated Tablet is a film-coated tablet formulated with Diclofenac Potassium 50 mg + Serratiopeptidase 10 mg. The active ingredient profile is Diclofenac Potassium; Serratiopeptidase, placing the pro

Available strengths
Diclofenac Potassium 50 mg + Serratiopeptidase 10 mg
TabletsSingle

Diclofenac Sodium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium Trisilicate 100 mg Uncoated Tablet

Uncoated Tablet

Diclofenac Sodium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium Trisilicate 100 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Sodium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium Trisi

Available strengths
Diclofenac Sodium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium Trisilicate 100 mg
Add to RFQ

Dapagliflozin 5mg + Metformin Hydrochloride IP 500 mg (Film coated bilayred Tablet)

Add to RFQ

Dapagliflozin 5mg Tablets (Film coated)

Add to RFQ

Deflazacort 6 mg Uncoated Tablet

Add to RFQ

Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg Uncoated Tablet

Add to RFQ

Diclofenac Potassium 50 mg + Paracetamol 325 mg + Serratiopeptidase 10 mg Film-Coated Tablet

Quality-led sourcing

Why Choose Decure for Human Formulations?

GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive Pricing
B2B pharmaceutical sourcing

Looking for Specific Formulations or Large Quantities?

Our sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.

RFQ List (0)